VIRIDIAN THERAPEUTICS INC's ticker is VRDN and the CUSIP is 92790C104. A total of 106 filers reported holding VIRIDIAN THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is 0.26 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $928,013 | -34.4% | 60,497 | +1.7% | 0.00% | -50.0% |
| Q2 2023 | $1,415,076 | +104876.0% | 59,482 | +12.3% | 0.00% | 0.0% |
| Q1 2023 | $1,348 | -2.3% | 52,968 | +12.1% | 0.00% | 0.0% |
| Q4 2022 | $1,380 | -99.8% | 47,253 | +35.5% | 0.00% | +100.0% |
| Q3 2022 | $715,000 | +94.8% | 34,863 | +9.9% | 0.00% | 0.0% |
| Q2 2022 | $367,000 | – | 31,713 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| COMMODORE CAPITAL LP | 2,696,340 | $55,302,000 | 8.89% |
| TCG Crossover Management, LLC | 1,164,000 | $23,874,000 | 7.16% |
| VR Adviser, LLC | 2,130,308 | $43,693,000 | 6.74% |
| Fairmount Funds Management LLC | 1,369,623 | $28,091,000 | 4.94% |
| Paradigm Biocapital Advisors LP | 1,636,211 | $33,559,000 | 4.47% |
| Kynam Capital Management, LP | 1,000,000 | $20,510,000 | 4.32% |
| Vivo Capital, LLC | 1,660,019 | $34,047,000 | 3.76% |
| ACUTA CAPITAL PARTNERS, LLC | 362,735 | $7,440,000 | 3.20% |
| Ghost Tree Capital, LLC | 535,000 | $10,973,000 | 3.08% |
| Logos Global Management LP | 1,000,000 | $20,510,000 | 2.52% |